Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Other Non-Current Assets (2021 - 2022)

Axsome Therapeutics' Other Non-Current Assets history spans 2 years, with the latest figure at $507464.0 for Q2 2022.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $507464.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $507464.0, a N/A change, with the full-year FY2021 number at $322910.0, changed N/A from a year prior.
  • Other Non-Current Assets hit $507464.0 in Q2 2022 for Axsome Therapeutics, up from $322910.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for AXSM hit a ceiling of $507464.0 in Q2 2022 and a floor of $322910.0 in Q4 2021.